Paul Chaplin, Bavarian Nordic CEO

US gov­ern­ment or­ders 2.5M more mon­key­pox vac­cine dos­es from Bavar­i­an Nordic via CMO

With the FDA giv­ing the thumbs up for more mon­key­pox vac­cines to come from Bavar­i­an Nordic’s man­u­fac­tur­ing fa­cil­i­ty in Den­mark, the US gov­ern­ment is ask­ing for a lot more as the CDC marks the to­tal case count north of 1,400 peo­ple.

BAR­DA has asked the Dan­ish vac­cine man­u­fac­tur­er for 2.5 mil­lion more dos­es of their Jyn­neos vac­cine, a non-repli­cat­ing small­pox vac­cine and the on­ly FDA-ap­proved vac­cine against mon­key­pox and will be go­ing to the strate­gic na­tion­al stock­pile, or SNS.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.